Sun Pharma announced a 15 per cent year-on-year (YoY) increase, reaching ₹2,903 crore for the quarter ending December 2024. The company also recorded an exceptional item of ₹316 crore during ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 dropped 2.40% to 1,704.65 Indian rupees Friday, on what proved to be an all-around dismal trading session for the stock market, with the BSE ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 rallied 3.12% to 1,746.50 Indian rupees Thursday, on what proved to be an all-around grim trading session for the stock market, with the BSE ...

Caught amidst tariff concerns shares of India's prominent drugmakers--Dr Reddy's Laboratories, Sun Pharma, Lupin, Cipla, Zydus Life and Aurobindo Pharma--slipped 1-4 percent. These companies have ...

Sun Pharmaceutical , India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong sales in the domestic market. Top Indian drugmaker Sun Pharma ...

Sun Pharmaceutical Industries or Sun Pharma is India’s leading pharmaceutical firm which is known for the production of Active Pharmaceutical Ingredients (APIs). The company is headquartered in ...

Considering today's low, the Nifty pharma index has fallen over 7 per cent in the last three days. On a monthly scale, the index has declined nearly 12 per cent against a 3 per cent fall in the ...

Sun Pharma Advanced Research Company Ltd share price was down by -4.05% from the previous closing price of ₹156.20. Who are peers of Sun Pharma Advanced Research Company Ltd? The peers of Sun ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

BENGALURU (Reuters) -India's drug regulator has found more than 50 drugs, including some batches of widely used antacids and paracetamol, to be substandard or fake, according to government documents.